NeuraMatrix
Founded Year
2019Stage
Series A | AliveTotal Raised
$15.65MLast Raised
$15.65M | 6 mos agoAbout NeuraMatrix
NeuraMatrix is a limited liability company aiming to develop an implantable neural interface for frontier neuroscience research and future applications. It is based in Beijing, Beijing.
NeuraMatrix Headquarter Location
Room 1801 1, Floor 18, Building 3 No. 6 Lize West Street
Beijing, Beijing, 100020,
China
Expert Collections containing NeuraMatrix
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
NeuraMatrix is included in 3 Expert Collections, including Medical Devices.
Medical Devices
7,909 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Digital Health
12,785 items
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Health IT
7,900 items
Latest NeuraMatrix News
Nov 24, 2021
Brain-Machine Interface Startup NeuraMatrix Bags A Round of Financing Worth 100 Million Yuan (Source: Arabnews) After completing the A round of financing, NeuraMatrix said that it will increase investment in the R&D and mass production of chips, promote software and hardware development, and accelerate mass production of medical and scientific research equipment. NeuraMatrix, founded in November 2019, is a startup incubated by Tsinghua University. In March of this year, the company just completed a multi-million dollar Pre-A round of financing. The company’s goal is to build a brain-computer interface platform integrating materials, chips, hardware equipment and software. NeuraMatrix’s technical focus is an implantable brain-computer interface that will be physically placed within the brain. Because the implantable brain-computer interface can obtain a much more comprehensive high-quality signal from low to high frequencies, as equipment becomes smaller and the progress of implanting technology and materials increases, this new type of brain implant is considered to be better able to meet the needs of medical and intelligent interactions. According to the company, the commercial chip of bidirectional brain-computer interfaces developed by NeuraMatrix has finished tapeout. It is expected that the mass production of equipment equipped with the company’s self-developed chip will appear early next year. Moreover,, the company’s first prototype of wireless implantable brain-computer interface equipment has also started to be used by customers. At present, NeuraMatrix has signed a plethora of equipment purchase intent orders with many research institutes, hospitals and pharmaceutical companies.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.